<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Treyer A</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Treatment with cannabis extracts for a variety of diseases has gained popularity. However, differences in herb-drug interaction potential of extracts from different plant sources are poorly understood. In this study, we provide a characterization of cannabis extracts prepared from four cannabis chemotypes and an in vitro assessment of their Cytochrome P450 (CYP)-mediated herb-drug interaction profiles.&lt;h4>Methods&lt;/h4>Plant extracts were either commercially obtained or prepared using ethanol as solvent, followed by overnight decarboxylation in a reflux condenser system. The extracts were characterized for their cannabinoid content using NMR and HPLC-PDA-ELSD-ESIMS. CYP inhibition studies with the cannabis extracts and pure cannabinoids (tetrahydrocannabinol [THC] and ca</pubmed_abstract><journal>Medical cannabis and cannabinoids</journal><pagination>21-31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9940649</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Phytochemical Comparison of Medicinal Cannabis Extracts and Study of Their CYP-Mediated Interactions with Coumarinic Oral Anticoagulants.</pubmed_title><pmcid>PMC9940649</pmcid><pubmed_authors>Oufir M</pubmed_authors><pubmed_authors>Treyer A</pubmed_authors><pubmed_authors>Eigenmann DE</pubmed_authors><pubmed_authors>Reinhardt JK</pubmed_authors><pubmed_authors>Hamburger M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phytochemical Comparison of Medicinal Cannabis Extracts and Study of Their CYP-Mediated Interactions with Coumarinic Oral Anticoagulants.</name><description>&lt;h4>Introduction&lt;/h4>Treatment with cannabis extracts for a variety of diseases has gained popularity. However, differences in herb-drug interaction potential of extracts from different plant sources are poorly understood. In this study, we provide a characterization of cannabis extracts prepared from four cannabis chemotypes and an in vitro assessment of their Cytochrome P450 (CYP)-mediated herb-drug interaction profiles.&lt;h4>Methods&lt;/h4>Plant extracts were either commercially obtained or prepared using ethanol as solvent, followed by overnight decarboxylation in a reflux condenser system. The extracts were characterized for their cannabinoid content using NMR and HPLC-PDA-ELSD-ESIMS. CYP inhibition studies with the cannabis extracts and pure cannabinoids (tetrahydrocannabinol [THC] and ca</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan-Dec</publication><modification>2026-03-17T16:06:28.42Z</modification><creation>2025-04-06T14:44:37.179Z</creation></dates><accession>S-EPMC9940649</accession><cross_references><pubmed>36814687</pubmed><doi>10.1159/000528465</doi></cross_references></HashMap>